Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey.
Aboriginal and Torres Strait Islander people
cross-sectional survey
illicit drug use
methamphetamine
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
30
09
2019
revised:
10
02
2020
accepted:
08
04
2020
pubmed:
24
6
2020
medline:
9
11
2021
entrez:
24
6
2020
Statut:
ppublish
Résumé
There is a need for detailed information on methamphetamine use in Aboriginal and Torres Strait Islander communities. We describe a national survey on methamphetamine use among Aboriginal and Torres Strait Islander people and non-Indigenous people. Participants aged 16 years or older who reported using methamphetamine in the past year were recruited for a cross-sectional survey through 10 Aboriginal Community Controlled Organisations. Surveys were completed anonymously on electronic tablets. Measures included the Australian Treatment Outcomes Profile, the Severity of Dependence Scale, subscales from Opiate Treatment Index and the Kessler 10. A Chronic Stress Scale was used to assess culturally situated chronic stress factors. Of the 734 participants, 416 (59%) were Aboriginal or Torres Strait Islander and 331 (45%) were female. In the previous year, most participants reported smoking (48.7%) or injecting (34%) methamphetamine and 17.4% reported daily use. Aboriginal and Torres Strait Islander people did not differ significantly from non-Indigenous participants on methamphetamine use patterns (age at first use, frequency of use, main mode of use, injecting risk, poly drug use). Aboriginal and Torres Strait Islander participants felt less able to access health care (32% vs. 48%, P < 0.001), including mental health services (19% vs. 29%, P < 0.002), were less likely to report a mental health diagnosis (50% vs. 60%, P < 0.002) and were more likely to turn to family for support (52% vs. 34%, P < 0.001). We recruited and surveyed a large sample of Aboriginal and Torres Strait Islander people from which we can derive detailed comparative data on methamphetamine use and related health service needs for Aboriginal and Torres Strait Islander and non-Indigenous Australians.
Substances chimiques
Methamphetamine
44RAL3456C
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
646-655Subventions
Organisme : National Health and Medical Research Council
ID : APP#1100696
Pays : International
Organisme : Sylvia and Charles Viertel Senior Medical Research Fellowship
Pays : International
Informations de copyright
© 2020 Australasian Professional Society on Alcohol and other Drugs.
Références
Roche A, McEntee A. Ice and the outback: patterns and prevalence of methamphetamine use in rural Australia. Aust J Rural Health 2017;25:200-9.
Australian Institute of Health and Welfare. Trends in methylamphetamine availability, use and treatment, 2003-04 to 2013-14. Canberra: Australian Institute of Health and Welfare, 2015.
GBD 2016 Alcohol and Drug Use Collaborators. The global burden of disease attibutable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry 2018;5:987-1012.
Degenhardt L, Grant S, McKetin R et al. Crystalline methamphetamine use and methamphetamine related harms in Australia. Drug Alcohol Rev 2017;36:160-70.
Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2016: detailed findings. Canberra: Australian Institute of Health and Welfare, 2017.
Australian Bureau of Statistics. National Aboriginal and Torres Strait Islander social survey 2014-2015. 4714.0. Canberra: Australian Bureau of Statistics, 2016.
Snijder M, Kershaw S. Review of methamphetamine use among Aboriginal and Torres Strait Islander people. Aust Indig Health Bull 2019;19. Available at: http://healthbulletin.org.au/articles/review-of-methamphetamine/ (accessed August 2019).
Hamilton M, Dunlop AJ. ‘Ice’ (crystal methamphetamine): concerns and responses. Med J Aust 2016;204:136-7.
Peacock A, Gibbs D, Karlsson A et al. Australian drug trends 2018: key findings from the national ecstasy and related drugs reporting system (EDRS) interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Australia, 2018.
Peacock A, Gibbs D, Sutherland R et al. Australian drug trends 2018. Key findings from the national illicit drug reporting system (IDRS) interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Australia; 2018.
Ward J, Bryant J, Wand H et al. The Goanna survey: results of the first Australian study of knowledge, risk practices and health services access for sexually transmissible infections and blood borne viruses among young Aboriginal and Torres Strait Islander people. Alice Springs: Baker IDI Heart and Diabetes Institute, 2014.
Australian Institute of Health and Welfare. Aboriginal and Torres Strait Islander health organisations. Online services report-key results 2016-17. Aboriginal and Torres Strait Islander health servcies report no. 9. Cat. no. IHW 196. Canberra: Australian Institute of Health and Welfare, 2018.
Australian Institute of Health and Welfare. Aboriginal and Torres Strait Islander health organisation: Online Services Report-key results 2014-2015. Aboriginal and Torres Strait Islander health services report no 7 IHW 168. Canberra: Australian Institute of Health and Welfare, 2016.
McKetin R, Najman JM, Baker AL et al. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the methamphetamine treatment evaluation study (MATES). Addiction 2012;107:1998-2008.
McKetin R, Lubman DI, Najman JM, Dawe S, Butterworth P, Baker AL. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction 2014;109:798-806.
Ryan A, Holmes J, Hunt V et al. Validation and implementation of the Australian treatment outcomes profile in specialist drug and alcohol settings. Drug Alcohol Rev 2014;33:33-42.
Gossop M, Darke S, Griffiths P et al. The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:607-14.
Darke S, Hall W, Wodak A et al. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992;87:733-42.
Andrews G, Slade TN. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health 2001;25:494-7.
Brown A, Mentha R, Howard M et al. Men, hearts and minds: developing and piloting culturally appropriate psychometric tools assessing psychological stress and depression in central Australian Aboriginal men. Soc Psychiatry Psychiatr Epidemiol 2015;51:211-23.
Platt L, Wall M, Rhodes T et al. Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health 2006;83:39-53.
Power R. Some methodological and practical implications of employing drug users as indigenous fieldworkers. In: Boulton M, ed. Challenge and innovation: Methodological advances in social research on HIV/AIDS. London: Taylor and Francis, 1994:97-109.
Griffiths P, Gossop M, Powis B et al. Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues. Addiction 1993;88:1617-26.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81.
Johnson TP. Sources of error in substance use prevalence surveys. Int Sch Res Notices 2014;2014:923290.
Barratt MJ, Ferris JA, Zahnow R et al. Moving on from representativeness: testing the utility of the global drug survey. Subst Abus 2017;11:1178221817716391.
Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health 2005;27:281-91.
Darke S, Kaye S, Topp L. Cocaine use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system. Drug Alcohol Depend 2002;67:81-8.
Topp L, Breen C, Kaye S, Darke S. Adapting the illicit drug reporting system (IDRS) to examine the feasibility of monitoring trends in the markets for 'party drugs'. Drug Alcohol Depend 2004;73:189-97.
Commonwealth of Australia. National ice action strategy. Canberra: Commonwealth of Australia, 2015.
Davidson P, Saunders P, Bradbury B et al. Poverty in Australia, 2018. ACOSS/UNSW Poverty and Inequality Partnership Report No. 2. Sydney: ACOSS, 2018.
Nosrati E, Kang-Brown J, Ash M, McKee M, Marmot M, King LP. Economic decline, incarceration, and mortality from drug use disorders in the USA between 1983 and 2014: an observational analysis. Lancet Public Health 2019;4:e326-e33.
Thompson RG Jr, Wall MM, Greenstein E, Grant BF, Hasin DS. Substance-use disorders and poverty as prospective predictors of first-time homelessness in the United States. Am J Public Health 2013;103(Suppl 2):S282-S8.
Buck J, Siegel JA. The effects of adolescent methamphetamine exposure. Front Neurosci 2015;9:151.
Crouse JJ, Chitty KM, Iorfino F et al. Exploring associations between early substance use and longitudinal socio-occupational functioning in young people engaged in a mental health service. PLoS One 2019;214:e0210877.
Cho AK. Ice: a new dosage form of an old drug. Science 1990;249:631-4.
McKetin R, Kelly E, McLaren J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug Alcohol Depend 2006;85:198-204.
McKetin R, Ross J, Kelly E et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 2008;27:277-85.
Lee K, Jagtenberg M, Ellis CM et al. Pressing need for more evidence to guide efforts to address substance use among young Indigenous Australians. Health Prom J Aust 2013;54:87-97.
Kelly K, Dudgeon P, Gee G et al. Living on the edge: social and emotional wellbeing and risk and protective factors for serious psychological distress among Aboriginal and Torres Strait Islander people. Cooperative Research Centre for Aboriginal Health Discussion Paper No. 10. Darwin: Cooperative Research Centre for Aboriginal Health, 2009.
Kirby Institute. Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people: annual surveillance report 2018. Sydney: Kirby Institute, UNSW, 2018.
Canadian Centre on Substance Use and Addiction. Canadian drug summary: methamphetamine. Ottawa: Canadian Centre on Substance Use and Addiction, 2018.
Uhanova J, Tate R, Tataryn DJ, Minuk GV. The epidemiology of hepatitis C in a Canadian Indigenous population. Can J Gastroenterol 2013;27:336-40.
Challacombe L. The epidemiology of HIV in people who inject drugs in Canada. CATIE Fact Sheet. Toronto: CATIE; 2019.
House of Commons Canada. Impacts of methamphetamine abuse in Canada: report to the Standing Committee on Health. 42nd Parliament, first session, 2019.
Lloyd B, Heilbronn C. Challenges and opportunities for innovation in alcohol and drug epidemiological research. Australas Epidemiol 2014;21:6-9.